Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Viral Hepat ; 22(1): 55-63, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24548489

RESUMO

Hepatitis D virus (HDV) infection is acquired as a co- /superinfection of Hepatitis B virus (HBV) and can modulate the pathophysiology of chronic hepatitis B and related liver diseases including hepatocellular carcinoma. Among the eight distinct HDV genotypes reported, relatively few studies have attempted to investigate the prevalence of HDV mixed genotypes and RNA recombination of HDV. With a recorded prevalence of 10-20% HBV infection in Vietnam, this study investigated the HDV variability, HDV genotypes and HDV recombination among twenty-one HDV isolates in Vietnamese HBsAg-positive patients. HDV subgenomic and full-length genome sequences were obtained using newly established HDV-specific RT-PCR techniques. The nucleotide homology was observed from 74.6% to 99.4% among the investigated full-length genome of the HDV isolates. We observed HDV genotype 1 and HDV genotype 2 in the investigated Vietnamese patients. Although no HDV genotype mixtures were observed, we report here a newly identified recombinant of HDV genotypes (HDV 1 and HDV 2). The identified recombinant HDV isolate C03 revealed sequence homology to both HDV genotype 1 (nt1 to nt907) and HDV genotype 2 (nt908 to nt1675; HDAg coding region) with a breakpoint at nt908. Our findings demonstrate the prevalence of intergenotypic recombination between HDV genotypes 1 and 2 in a Vietnamese HBsAg-positive patient. Extended investigation on the distribution and prevalence of HDV, HDV mixed genotypes and recombinant HDV genotypes in a larger Vietnamese population offers vital insights into understanding of the micro-epidemiology of HDV and subsequent pathophysiology in chronic HBV- /HDV-related liver diseases.


Assuntos
Variação Genética , Antígenos de Superfície da Hepatite B/sangue , Hepatite B/complicações , Hepatite D/virologia , Vírus Delta da Hepatite/classificação , Vírus Delta da Hepatite/genética , Adulto , Idoso , Povo Asiático , Feminino , Genótipo , Vírus Delta da Hepatite/isolamento & purificação , Humanos , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Filogenia , RNA Viral/genética , Recombinação Genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Análise de Sequência de DNA , Homologia de Sequência , Adulto Jovem
2.
J Viral Hepat ; 12(2): 160-7, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15720531

RESUMO

Numerous mutations in the hepatitis B virus (HBV) genome have been described, but in most cases their role in the pathogenesis of HBV infection is still unclear. Therefore, we analysed specific mutations in HBV-infected Vietnamese patients and assessed their potential relationship with their clinical outcome. A total of 153 HBV-infected Vietnamese patients with well-characterised clinical profiles were enrolled. None of the study participants had a history of alcohol or drug use and none received any antiviral or immunosuppressive therapy before or during the course of this study. The HBx- and core promoter regions were analysed by sequencing. The majority of isolates corresponded to genotype A. The presence of hepatitis B e antigen (HBeAg) was associated with significantly higher viral loads in the chronic HBV-infection group (P = 0.026). Double mutations in the core promoter (1762/1764) were more frequent in those with cancer than in noncancer patients (P < 0.01). Mutations at nucleotide (nt) 1766/1773 were found at low prevalence but with no obvious association to clinical presentation. Cytosine at nt 1858 was predominant but the stop codon mutation in the precore region was not detected. In the study, 4/48 hepatocellular carcinoma (HCC) patients revealed truncated HBx, whilst the serine to alanine mutation (codon 31) of HBx was more prevalent in cancer patients than in asymptomatic HBV carriers (P < 0.01). Thus, the low frequency of mutations indicates the relation of the absence of antiviral pressure in this population. The exclusively found prevalence of certain mutations detected in those with HBV-related carcinoma nevertheless indicates a degree of association with disease progression.


Assuntos
Antígenos do Núcleo do Vírus da Hepatite B/genética , Vírus da Hepatite B/genética , Hepatite B/etnologia , Hepatite B/genética , Mutação , Adulto , Sequência de Bases , Estudos de Casos e Controles , Estudos de Coortes , DNA Viral/análise , Progressão da Doença , Feminino , Marcadores Genéticos/genética , Hepatite B/fisiopatologia , Heterozigoto , Humanos , Testes de Função Hepática , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Probabilidade , Regiões Promotoras Genéticas , Sensibilidade e Especificidade , Índice de Gravidade de Doença , Vietnã
3.
Wien Klin Wochenschr ; 112(10): 451-2, 2000 May 19.
Artigo em Inglês | MEDLINE | ID: mdl-10890137

RESUMO

The effect of ethanol on the in vitro growth of the malaria parasite Plasmodium falciparum was investigated. 17 mM (0.08%) and 85 mM (0.39%) ethanol were added to parasite cultures and growth was determined for six days. A significant growth inhibition for both ethanol concentrations was observed on each day. It reached 65% for 85 mM ethanol after six days of incubation. Malarial parasites are strongly inhibited by ethanol concentrations which are attainable by extensive alcohol consumption.


Assuntos
Consumo de Bebidas Alcoólicas , Anti-Infecciosos/farmacologia , Etanol/farmacologia , Malária/prevenção & controle , Plasmodium falciparum/efeitos dos fármacos , África/epidemiologia , Animais , Anti-Infecciosos/uso terapêutico , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Etanol/uso terapêutico , Técnicas In Vitro , Plasmodium falciparum/parasitologia
4.
Am J Trop Med Hyg ; 57(5): 594-600, 1997 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9392601

RESUMO

A single Plasmodium falciparum isolate was adapted for growth in serum-free culture medium. The parasitemia increased from 0.5% to 20% on day 7 after thawing. The asexual forms of the parasites appeared morphologically normal and pigment formation was comparable with that seen under standard conditions with serum present. Parasites were coincubated in 96-well plates with serum, peripheral blood mononuclear cells (PBMC), and PBMC in the presence of autologous serum from healthy non-immune individuals (n = 12), healthy semi-immune individuals (n = 12), and malaria patients (n = 7). Growth was monitored for six days. The concentration of interleukin-6 and interferon-gamma (IFN-gamma) in supernatants from the continuous cultures were measured by a bioassay and an enzyme-amplified sensitivity immunoassay. The results of this study showed that parasites cultured in serum-free medium in the presence of PBMC develop more rapidly, particularly with cells from malaria patients, compared with parasites cultured alone. The growth of parasites was different if 10% autologous serum was added to the culture. Parasite growth with sera from acutely infected individuals was similar with that with sera from aparasitemic, nonimmune individuals, and both supported significantly higher parasite growth over the six-day culture period compared with sera from the uninfected semi-immune individuals. Production of IFN-gamma by cells from nonimmune individuals and malaria patients was higher when cultures did not contain autologous serum. Nonimmune donor cells produced high amounts of IFN-gamma, but cells from the semi-immune donors produced little of this cytokine. There was no marked inhibition of parasite growth with any combination of serum and cells over six days of culture. A difference between the groups was observed after two days of culture, when growth with cells and serum from the uninfected, semi-immune group was significantly lower than that from the nonimmune group, but this was not subsequently sustained. The results of the study show that continuous cultivation of P. falciparum in serum-free medium provides a novel in vitro model to study mechanisms of the interplay between components of the human immune system and the malarial parasite, in which any possible influence of human serum is removed.


Assuntos
Leucócitos Mononucleares/fisiologia , Plasmodium falciparum/crescimento & desenvolvimento , Adolescente , Adulto , Animais , Meios de Cultura Livres de Soro , Citocinas/biossíntese , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...